UBS strategist Joni Teves is breaking her own rules — so are strategists at Goldman Sachs.

A likely delay in tougher new capital rules for UBS has fed uncertainty about the outlook for the Swiss bank but also paused ...

UBS analyst Matthew Weston maintained a Buy rating on Merck KGaA (0O14 – Research Report) today and set a price target of €190.00. The ...

Expectations of a banner year in dealmaking have not yet materialized due to worries about inflation and uncertainties over U ...

New banking rules for UBS could face a long delay after Switzerland's finance ministry on Wednesday said it wanted lawmakers ...

In a report released today, Graham Doyle from UBS maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research ...

Gold's (GC=F) glittering run in 2025 may have more room to rise higher, Goldman Sachs believes. On Tuesday ... In a gold note ...